Insights on Clinical Trials

  1. A Sponsor's Blueprint For Maintaining Compliance And Ethics In Gene Therapy Trials For Neurological Conditions 10/29/2025

    To identify efficacious treatments for neurological conditions, drug sponsors must design ethical clinical trials that protect participants and caregivers while ensuring compliance with regulators.

  2. Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment 10/27/2025

    Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.

  3. The Immunotherapy Revolution's Path To Precision 10/27/2025

    Learn how comprehensive immune profiling and translational models can illuminate these mechanisms, inform dose selection, and guide the next generation of immunotherapies toward safer, more targeted innovation.

  4. Advancing The Use Of AI Tools In Hepatology Drug Development 10/27/2025

    Explore how AI can help overcome key challenges in hepatology trials — from site selection and patient matching to data integration and engagement — while ensuring diversity, privacy, and transparency.

  5. The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets 10/27/2025

    Learn how to streamline development, reduce costs, and accelerate the path to market for next-generation RNA therapies.

  6. Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical Trials 10/24/2025

    Discover the most effective regulatory pathways used to support CGT development, including two real-life examples.

  7. Ensure IRB And IBC Success For Your Gene Therapy With Strategic Planning 10/23/2025

    To successfully bring innovative gene therapies to patients with neurological disorders, drug sponsors must design safe and compliant clinical trials with rigorous approaches to ethics and consent.

  8. The Hidden Cost Of Preferred Vendors 10/21/2025

    Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.

  9. Navigating Biases In Clinical Trial Vendor Selection 10/21/2025

    Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.

  10. The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials 10/21/2025

    Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.